콜레스테롤 검사 서비스 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Cholesterol Testing Services Market is presumed to reach the market size of nearly USD 55.04 Billion by 2032 from USD 26.06 Billion in 2023 with a CAGR of 8.66% under the study period 2024-2032.

Cholesterol testing services provide diagnostic evaluations to measure lipid levels in the blood, comprising total cholesterol, HDL (high-density lipoprotein), LDL (low-density lipoprotein), and triglycerides. These tests are essential for assessing cardiovascular health and identifying heart disease and stroke risks. Typically conducted in clinical laboratories, hospitals, or through at-home testing kits, these services help individuals monitor their cholesterol levels and make informed lifestyle and treatment decisions. Regular cholesterol testing is vital for early detection of hyperlipidemia, guiding preventive measures, and managing conditions with dietary changes, medications, or other therapeutic interventions to maintain optimal heart health.

MARKET DYNAMICS

The surging prevalence of cardiovascular diseases (CVDs), such as coronary artery disease, peripheral artery disease, and stroke, attributed to risk factors like sedentary lifestyles, unhealthy dietary habits, and obesity, drives market demand for cholesterol testing services as a crucial component of preventive healthcare and disease management strategies. This growing disease burden underscores the importance of routine cholesterol screening and monitoring to assess cardiovascular risk and guide treatment decisions, fuelling market growth for testing services. Advancements in diagnostic technologies and point-of-care testing devices enable convenient and rapid cholesterol testing, enhancing patient access and compliance while reducing turnaround times and healthcare costs.

Additionally, increasing public awareness and education campaigns about the importance of cholesterol management and heart health contribute to market expansion by promoting preventive screening and early intervention initiatives. Moreover, expanding healthcare infrastructure and access to primary care services, particularly in emerging economies, drive market penetration by broadening patient access to cholesterol testing services in diverse clinical settings. Furthermore, supportive regulatory policies and reimbursement frameworks for preventive screenings and cardiovascular risk assessments encourage healthcare providers to offer cholesterol testing services, stimulating market demand. However, the high cost of services and limited access to testing facilities may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cholesterol Testing Services. The growth and trends of Cholesterol Testing Services industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cholesterol Testing Services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Test Type

• Total Cholesterol Tests
• High Density Lipoprotein (HDL) Cholesterol Tests
• Low Density Lipoprotein (LDL) Cholesterol Tests
• Triglyceride Tests
• Other

By Product Type

• Testing Kits
• Testing Strips
• Other

By Application

• Cardiovascular Diseases
• Diabetes
• Obesity
• Hyperlipidemia
• Other

By Age Group

• Geriatric
• Adult
• Pediatric

By Service Provider

• Hospitals And Clinics
• Diagnostic Laboratories
• Ambulatory Care Centers
• Other

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cholesterol Testing Services market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cholesterol Testing Services market include Abbott Laboratories, Accu Reference Medical Lab LLC, Atherotech Diagnostics Lab, Bio-Reference Laboratories Inc., Boston Heart Diagnostics Corporation, Cell Biolabs Inc., Clinical Reference Laboratory Inc., Eurofins Scientific, Mayo Clinic Laboratories, Quest Diagnostics Incorporated, Randox Laboratories Limited, Sonic Healthcare Limited, SpectraCell Laboratories Inc., Synlab Holding Deutschland GmbH, Thermo Fisher Scientific Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. CHOLESTEROL TESTING SERVICES - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Test Type
  • 3.7.2 Market Attractiveness Analysis By Product Type
  • 3.7.3 Market Attractiveness Analysis By Application
  • 3.7.4 Market Attractiveness Analysis By Age Group
  • 3.7.5 Market Attractiveness Analysis By Service Provider
  • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CHOLESTEROL TESTING SERVICES MARKET ANALYSIS BY TEST TYPE

• 5.1. Overview By Test Type
• 5.2. Historical and Forecast Data Analysis By Test Type
• 5.3. Total Cholesterol Tests Historic and Forecast Sales By Regions
• 5.4. High Density Lipoprotein (HDL) Cholesterol Tests Historic and Forecast Sales By Regions
• 5.5. Low Density Lipoprotein (LDL) Cholesterol Tests Historic and Forecast Sales By Regions
• 5.6. Triglyceride Tests Historic and Forecast Sales By Regions
• 5.7. Other Historic and Forecast Sales By Regions

6. GLOBAL CHOLESTEROL TESTING SERVICES MARKET ANALYSIS BY PRODUCT TYPE

• 6.1. Overview By Product Type
• 6.2. Historical and Forecast Data Analysis By Product Type
• 6.3. Testing Kits Historic and Forecast Sales By Regions
• 6.4. Testing Strips Historic and Forecast Sales By Regions
• 6.5. Other Historic and Forecast Sales By Regions

7. GLOBAL CHOLESTEROL TESTING SERVICES MARKET ANALYSIS BY APPLICATION

• 7.1. Overview By Application
• 7.2. Historical and Forecast Data Analysis By Application
• 7.3. Cardiovascular Diseases Historic and Forecast Sales By Regions
• 7.4. Diabetes Historic and Forecast Sales By Regions
• 7.5. Obesity Historic and Forecast Sales By Regions
• 7.6. Hyperlipidemia Historic and Forecast Sales By Regions
• 7.7. Other Historic and Forecast Sales By Regions

8. GLOBAL CHOLESTEROL TESTING SERVICES MARKET ANALYSIS BY AGE GROUP

• 8.1. Overview By Age Group
• 8.2. Historical and Forecast Data Analysis By Age Group
• 8.3. Geriatric Historic and Forecast Sales By Regions
• 8.4. Adult Historic and Forecast Sales By Regions
• 8.5. Pediatric Historic and Forecast Sales By Regions

9. GLOBAL CHOLESTEROL TESTING SERVICES MARKET ANALYSIS BY SERVICE PROVIDER

• 9.1. Overview By Service Provider
• 9.2. Historical and Forecast Data Analysis By Service Provider
• 9.3. Hospitals And Clinics Historic and Forecast Sales By Regions
• 9.4. Diagnostic Laboratories Historic and Forecast Sales By Regions
• 9.5. Ambulatory Care Centers Historic and Forecast Sales By Regions
• 9.6. Other Historic and Forecast Sales By Regions

10. GLOBAL CHOLESTEROL TESTING SERVICES MARKET ANALYSIS BY GEOGRAPHY

• 10.1. Regional Outlook
• 10.2. Introduction
• 10.3. North America Sales Analysis
  • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.3.2 North America By Segment Sales Analysis
  • 10.3.3 North America By Country Sales Analysis
  • 10.3.4 United States Sales Analysis
  • 10.3.5 Canada Sales Analysis
  • 10.3.6 Mexico Sales Analysis
• 10.4. Europe Sales Analysis
  • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.4.2 Europe By Segment Sales Analysis
  • 10.4.3 Europe By Country Sales Analysis
  • 10.4.4 United Kingdom Sales Analysis
  • 10.4.5 France Sales Analysis
  • 10.4.6 Germany Sales Analysis
  • 10.4.7 Italy Sales Analysis
  • 10.4.8 Russia Sales Analysis
  • 10.4.9 Rest Of Europe Sales Analysis
• 10.5. Asia Pacific Sales Analysis
  • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.5.2 Asia Pacific By Segment Sales Analysis
  • 10.5.3 Asia Pacific By Country Sales Analysis
  • 10.5.4 China Sales Analysis
  • 10.5.5 India Sales Analysis
  • 10.5.6 Japan Sales Analysis
  • 10.5.7 South Korea Sales Analysis
  • 10.5.8 Australia Sales Analysis
  • 10.5.9 South East Asia Sales Analysis
  • 10.5.10 Rest Of Asia Pacific Sales Analysis
• 10.6. Latin America Sales Analysis
  • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.6.2 Latin America By Segment Sales Analysis
  • 10.6.3 Latin America By Country Sales Analysis
  • 10.6.4 Brazil Sales Analysis
  • 10.6.5 Argentina Sales Analysis
  • 10.6.6 Peru Sales Analysis
  • 10.6.7 Chile Sales Analysis
  • 10.6.8 Rest of Latin America Sales Analysis
• 10.7. Middle East & Africa Sales Analysis
  • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.7.2 Middle East & Africa By Segment Sales Analysis
  • 10.7.3 Middle East & Africa By Country Sales Analysis
  • 10.7.4 Saudi Arabia Sales Analysis
  • 10.7.5 UAE Sales Analysis
  • 10.7.6 Israel Sales Analysis
  • 10.7.7 South Africa Sales Analysis
  • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE CHOLESTEROL TESTING SERVICES COMPANIES

• 11.1. Cholesterol Testing Services Market Competition
• 11.2. Partnership/Collaboration/Agreement
• 11.3. Merger And Acquisitions
• 11.4. New Product Launch
• 11.5. Other Developments

12. COMPANY PROFILES OF CHOLESTEROL TESTING SERVICES INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Market Concentration Rate
• 12.3. Abbott Laboratories
  • 12.3.1 Company Overview
  • 12.3.2 Company Revenue
  • 12.3.3 Products
  • 12.3.4 Recent Developments
• 12.4. Accu Reference Medical Lab LLC
  • 12.4.1 Company Overview
  • 12.4.2 Company Revenue
  • 12.4.3 Products
  • 12.4.4 Recent Developments
• 12.5. Atherotech Diagnostics Lab
  • 12.5.1 Company Overview
  • 12.5.2 Company Revenue
  • 12.5.3 Products
  • 12.5.4 Recent Developments
• 12.6. Bio-Reference Laboratories Inc.
  • 12.6.1 Company Overview
  • 12.6.2 Company Revenue
  • 12.6.3 Products
  • 12.6.4 Recent Developments
• 12.7. Boston Heart Diagnostics Corporation
  • 12.7.1 Company Overview
  • 12.7.2 Company Revenue
  • 12.7.3 Products
  • 12.7.4 Recent Developments
• 12.8. Cell Biolabs Inc.
  • 12.8.1 Company Overview
  • 12.8.2 Company Revenue
  • 12.8.3 Products
  • 12.8.4 Recent Developments
• 12.9. Clinical Reference Laboratory Inc.
  • 12.9.1 Company Overview
  • 12.9.2 Company Revenue
  • 12.9.3 Products
  • 12.9.4 Recent Developments
• 12.10. Eurofins Scientific
  • 12.10.1 Company Overview
  • 12.10.2 Company Revenue
  • 12.10.3 Products
  • 12.10.4 Recent Developments
• 12.11. Mayo Clinic Laboratories
  • 12.11.1 Company Overview
  • 12.11.2 Company Revenue
  • 12.11.3 Products
  • 12.11.4 Recent Developments
• 12.12. Quest Diagnostics Incorporated
  • 12.12.1 Company Overview
  • 12.12.2 Company Revenue
  • 12.12.3 Products
  • 12.12.4 Recent Developments
• 12.13. Randox Laboratories Limited
  • 12.13.1 Company Overview
  • 12.13.2 Company Revenue
  • 12.13.3 Products
  • 12.13.4 Recent Developments
• 12.14. Sonic Healthcare Limited
  • 12.14.1 Company Overview
  • 12.14.2 Company Revenue
  • 12.14.3 Products
  • 12.14.4 Recent Developments
• 12.15. SpectraCell Laboratories Inc.
  • 12.15.1 Company Overview
  • 12.15.2 Company Revenue
  • 12.15.3 Products
  • 12.15.4 Recent Developments
• 12.16. Synlab Holding Deutschland GmbH
  • 12.16.1 Company Overview
  • 12.16.2 Company Revenue
  • 12.16.3 Products
  • 12.16.4 Recent Developments
• 12.17. Thermo Fisher Scientific Inc
  • 12.17.1 Company Overview
  • 12.17.2 Company Revenue
  • 12.17.3 Products
  • 12.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies